Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.

Auteur(s) :
Larsen IK., Grotmol T., Almendingen K., Berg-Beckhoff G.
Date :
Avr, 2007
Source(s) :
CLIN GASTROENTEROL HEPATOL. #5:4 p477-83
Adresse :
The Cancer Registry of Norway, Institute of Population-based Cancer Research, Montebello, Norway.

Sommaire de l'article

BACKGROUND & AIMS: A potential downside of colorectal cancer screening is that a « health certificate effect » might have negative effects on lifestyle. The aim of the present randomized controlled trial was to evaluate lifestyle changes in a group of individuals offered flexible sigmoidoscopy screening compared with a control group and also in relation to screening outcome. METHODS: Men and women aged 50-55 years were drawn by randomization from the population registry to be invited for flexible sigmoidoscopy screening (n = 6961) or not to be invited (n = 7000). Both groups were asked to fill in a questionnaire on selected lifestyle indicators at baseline and 3 years later. From both rounds, 3598 pairs of completed questionnaires were available for analysis from the screening group and 3462 from the control group. RESULTS: Both groups revealed a desirable change in most lifestyle indicators. A weight gain in the screening group was, on average, 0.24 kg higher than in the control group (P = .023). The screening group had poorer improvement in score for smoking (mean difference, 0.05; P = .013) and exercise habits (mean difference, -0.12; P = .001) and a lower increase in servings/day of fruit, berries, and vegetables (mean difference, -0.10; P = .001) compared with controls. The weight gain in screen-negative individuals (ie, no neoplasia) was, on average, 0.5 kg (P = .020) more than for screen positives. CONCLUSIONS: The present study has demonstrated a possible health certificate effect of flexible sigmoidoscopy screening and screening outcome on lifestyle. Although modest, these findings indicate a potential need for patient education in screening programs.

PMID: 17363335 [PubMed – indexed

Source : Pubmed
Retour